RiiQ™ respiratory item† | Polychoric correlation | ||||
---|---|---|---|---|---|
a. Cough | b. Sore throat | d. Nasal congestion | j. Wheezing | k. Expectoration | |
Vaccine trial—ARI PRO eDiary Day 1 (n = 40) | |||||
a. Cough | – | ||||
b. Sore throat | 0.37 (0.04, 0.69) | – | |||
d. Nasal congestion | − 0.03 (− 0.40, 0.33) | − 0.16 (− 0.53, 0.20) | – | ||
j. Wheezing | 0.53 (0.22, 0.84) | 0.27 (− 0.11, 0.65) | − 0.10 (− 0.51, 0.31) | – | |
k. Expectoration | 0.58 (0.32, 0.84) | 0.19 (− 0.17, 0.54) | 0.02 (− 0.35, 0.40) | 0.55 (0.26, 0.85) | – |
l. Shortness of breath | 0.69 (0.44, 0.94) | 0.29 (− 0.09, 0.68) | 0.27 (− 0.12, 0.67) | 0.53 (0.19, 0.87) | 0.84 (0.69, 1.00) |
HARTI—baseline (n = 100) | |||||
a. Cough | – | ||||
b. Sore throat | 0.53 (0.31, 0.74) | – | |||
d. Nasal congestion | 0.33 (0.13, 0.54) | 0.35 (0.10, 0.60) | – | ||
j. Wheezing | 0.62 (0.47, 0.78) | 0.39 (0.15, 0.63) | 0.47 (0.29, 0.66) | – | |
k. Expectoration | 0.36 (0.16, 0.56) | 0.23 (− 0.03, 0.49) | 0.24 (0.03, 0.46) | 0.37 (0.17, 0.57) | – |
l. Shortness of breath | 0.65 (0.51, 0.80) | 0.51 (0.29, 0.72) | 0.40 (0.20, 0.60) | 0.76 (0.65, 0.87) | 0.21 (− 0.01, 0.43) |